Myeloproliferative Neoplasms News

St. Jude-Washington University Pediatric Cancer Genome Project yields ‘important new findings’ in childhood malignancies

ORLANDO, Fla. — The HemOnc Today and Healio.com/HemOnc team will present comprehensive live coverage from the ASH Annual Meeting and Exposition starting Dec. 5.

When an adolescent or young adult receives a cancer diagnosis, their life is completely interrupted.

Steven T. Rosen, MD, provost and chief scientific officer for City of Hope, received a Lifetime Achievement Award from the Israel Cancer Research Fund.

Amid the myriad concerns that accompany a cancer diagnosis, the risk for venous thromboembolism may be last on the minds of patients and clinicians.

HemOnc Today presents the most recent information about hematology drugs in the pipeline. Drugs listed here are in phase 2 or phase 3 development for a variety of indications. Clinicians can use this chart as a quick reference to learn about the status of those drugs that may be clinically significant to their practice. To view the entire chart online, go to www.Healio.com/HematologyPipeline.

Haploidentical stem cell transplantation recipients may achieve similar early immune recovery and clinical outcomes as patients undergoing allogeneic hematopoietic stem cell transplantation with HLA-matched donors, according to the results of a retrospective study.

ASH announced the election of three new members to its executive committee, the governing body of the organization.

Advances in immunotherapy have dramatically expanded the treatment armamentarium for both solid tumors and hematologic malignancies.

I have had the privilege of taking care of many young adult patients with lymphomas.